Related Experiment Videos

[The abnormal expression of epidermal growth factor receptor family in pterygium]

Z Liu1, Y Xie, M Zhang

  • 1Zhongshan Ophthalmic Center, Sun Yat-sen University of Medical Sciences, Guangzhou 510060, China. zuguol@gzsums.edu.cn

Abstract

Insights

Pterygium, a proliferative eye disorder, shows increased expression of epidermal growth factor receptor (EGFR), ErbB2, and ErbB3. This abnormal signaling may drive pterygium pathogenesis.

Area of Science:

  • Ophthalmology
  • Molecular Biology
  • Cell Biology

Background:

  • Pterygium is a common ocular surface disorder.
  • The pathogenesis of pterygium involves epithelial and stromal changes.
  • Growth factor receptor family members are implicated in cell proliferation.

Purpose of the Study:

  • To investigate the expression of type 1 growth factor receptor family members, specifically epidermal growth factor receptor (EGFR), ErbB2, and ErbB3, in pterygium epithelium.
  • To elucidate the role of these receptors in the pathogenesis of pterygium.

Main Methods:

  • Immunofluorescent staining and Western blotting were employed.
  • Samples from 15 primary pterygium patients and normal conjunctival epithelium were analyzed.
  • Expression levels of EGFR, ErbB2, and ErbB3 proteins were quantified.

Main Results:

  • In normal conjunctiva, EGFR was detected in basal cells, while ErbB2 and ErbB3 were in superficial cells.
  • Eleven out of 15 pterygia exhibited enhanced and full-thickness epithelial expression of EGFR, ErbB2, and ErbB3.
  • Western blotting confirmed increased protein density for EGFR, ErbB2, and ErbB3 in these 11 pterygia.

Conclusions:

  • Pterygium demonstrates elevated expression of EGFR, ErbB2, and ErbB3, indicating a proliferative nature.
  • Aberrant expression of these receptors in pterygium epithelium, potentially interacting with stromal cytokines, is a key factor in its pathogenesis.

Related Concept Videos